University Of Liverpool
The aim of the Roy Castle Lung Cancer Research Programme is to reduce lung cancer mortality by detecting lung cancer earlier. We believe this will be achieved by developing and implementing a molecular-epidemiological risk assessment model and markers of pre-clinical carcinogenesis, used in conjunction with low-dose CT screening.
The current lung cancer research programme focuses on the Liverpool Lung Project (LLP) and the UK Lung Cancer Screening trial (UKLS). We owe a debt of gratitude to all those who have supported these studies over the years as participants and funders. Special thanks go to the Roy Castle Lung Cancer Foundation, who have supported us since the start, over 20 years ago,
The success of the programme may be measured not only by its publication record but also the ability to attract significant funding from UK (CRUK, NIHR, PCTs), EU (FP5, FP7) and USA (NIH) as well as establishing strategic collaborations with academic and industrial partners, to undertake complementary studies in early lung cancer detection (ILCCO, TRICL, INTEGRAL).
The current Roy Castle Lung Cancer Research Programme objectives are: